The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy.

Front Oncol · 2022 · PMC9170883 · PMID 35686094

Europe PMC DOI

hedged sentence

0.1380

closest p · 2.8× alpha

0.1380

boldest claim

The sentences

showed a trendp = 0.138not close (p > 0.1)

Patients with no less than 54.4ng/ml in AFP BL showed a trend with better RFS than those who did not ( p = 0.138, Supplemental Materials Figure 1D ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.